{"id":"W4389803456","doi":"10.57264/cer-2023-0142","title":"Real-world use of inotuzumab ozogamicin is associated with lower health care costs than blinatumomab in patients with acute lymphoblastic leukemia in the first relapsed/refractory setting","year":2023,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer Pharmaceuticals; Pfizer","keywords":"Medicine; Blinatumomab; Refractory (planetary science); Lymphoblastic Leukemia; Retrospective cohort study; Internal medicine; Emergency medicine; Pediatrics; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005176687,0.0003925149,0.00149918,0.002812179,0.0002644342,0.00008589401,0.0005745637,0.0001670364,0.00001275053],"category_scores_gemma":[0.001017303,0.0002363991,0.0001430548,0.006381826,0.0006005765,0.0005083481,0.0002012383,0.002324688,0.00001249108],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.02126202,"about_ca_system_score_gemma":0.0085025,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001704897,"about_ca_topic_score_gemma":0.003251174,"domain_scores_codex":[0.9900847,0.003705452,0.0010105,0.0004913982,0.00361202,0.00109594],"domain_scores_gemma":[0.9849948,0.01037957,0.000746875,0.0005263137,0.003092377,0.0002600056],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04054499,0.001212314,0.9341351,0.0005978409,0.0008283295,0.002335743,0.01446685,0.002944137,0.0001831062,0.000047284,0.002225663,0.0004786398],"study_design_scores_gemma":[0.02199758,0.01171832,0.953966,0.006658928,0.00006498952,0.00004780143,0.002245453,0.002175144,0.0008171386,0.00001568051,0.00008705264,0.0002058833],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969078,0.00008911965,0.00004004653,0.000345081,0.00007846568,0.002198115,0.0000572686,0.0000180058,0.0002660993],"genre_scores_gemma":[0.9994836,0.0000716402,0.00006212103,0.00006160355,0.00005396119,0.00007370393,0.00005590924,0.00006415118,0.00007327188],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01983094,"threshold_uncertainty_score":0.999977,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04128034902075604,"score_gpt":0.37272352712147,"score_spread":0.3314431781007139,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}